1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF GLOBAL GUT HEALTH SUPPLEMENTS MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATION

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 KEY TAKEAWAYS

2.2 ARRIVING AT THE GLOBAL GUT HEALTH SUPPLEMENTS MARKET SIZE

2.2.1 VENDOR POSITIONING GRID

2.2.2 TECHNOLOGY LIFE LINE CURVE

2.2.3 MARKET GUIDE

2.2.4 COMPANY POSITIONING GRID

2.2.5 COMAPANY MARKET SHARE ANALYSIS

2.2.6 MULTIVARIATE MODELLING

2.2.7 DEMAND AND SUPPLY-SIDE VARIABLES

2.2.8 TOP TO BOTTOM ANALYSIS

2.2.9 STANDARDS OF MEASUREMENT

2.2.10 VENDOR SHARE ANALYSIS

2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS

2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES

2.3 GLOBAL GUT HEALTH SUPPLEMENTS MARKET : RESEARCH SNAPSHOT

2.4 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 CHALLENGES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

5.1 VALUE CHAIN ANALYSIS

5.2 SUPPLY CHAIN ANALYSIS

5.3 IMPORT-EXPORT ANALYSIS

5.4 PORTER’S FIVE FORCES ANALYSIS

5.4.1 BARGAINING POWER OF SUPPLIERS

5.4.2 BARGAINING POWER OF BUYERS/CONSUMERS

5.4.3 THREAT OF NEW ENTRANTS

5.4.4 THREAT OF SUBSTITUTE PRODUCTS

5.4.5 INTENSITY OF COMPETITIVE RIVALRY

5.5 RAW MATERIAL SOURCING ANALYSIS

5.6 OVERVIEW OF TECHNOLOGICAL INNOVATIONS

5.7 INDUSTRY TRENDS AND FUTURE PERSPECTIVE

5.8 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS

5.9 FACTORS INFLUENCING PURCHASING DECISION OF END-USERS

6 IMPACT OF ECONOMIC SLOW DOWN ON MARKET

6.1 IMPACT ON PRICE

6.2 IMPACT ON SUPPLY CHAIN

6.3 IMPACT ON SHIPMENT

6.4 IMPACT ON COMPANY’S STRATEGIC DECISIONS

7 REGULATORY FRAMEWORK AND GUIDELINES

8 BRAND OUTLOOK

8.1 COMPARATIVE BRAND ANALYSIS

8.2 PRODUCT VS BRAND OVERVIEW

9 GLOBAL GUT HEALTH SUPPLEMENTS MARKET , BY PRODUCT TYPE, 2020-2029, (USD MILLION) , (KILO TONS)

(ASP, VALUE AND VOLUME WILL BE PROVIDED FOR ALL THE SEGMENTS)

9.1 OVERVIEW

9.2 PROBIOTICS

9.2.1 ASP

9.2.2 VALUE

9.2.3 VOLUME

9.2.4 PROBIOTICS, BY TYPE

9.2.4.1. BIFIDOBACTERIA

9.2.4.1.1. BIFIDOBACTERIUM ADOLESCENTIS

9.2.4.1.2. BIFIDOBACTERIUM ANIMALIS

9.2.4.1.3. BIFIDOBACTERIUM BIFIDUM

9.2.4.1.4. BIFIDOBACTERIUM BREVE

9.2.4.1.5. BIFIDOBACTERIUM LONGUM

9.2.4.2. LACTOBACILLUS

9.2.4.2.1. LACTOBACILLUS ACIDOPHILUS

9.2.4.2.2. LACTOBACILLUS RHAMNOSUS

9.2.4.2.3. LACTOBACILLUS CASEI

9.2.4.2.4. LACTOBACILLUS REUTERI

9.2.4.2.5. LACTOBACILLUS FERMENTUM

9.2.4.2.6. LACTOBACILLUS GASSERI

9.2.4.2.7. LACTOBACILLUS JOHNSONII

9.2.4.2.8. LACTOBACILLUS PARACAASEI

9.2.4.2.9. LACTOBACILLUS PLANTARUM

9.2.4.2.10. LACTOBACILLUS SALIVARIUS

9.2.4.2.11. LACTOBACILLUS THERMOPHILUS

9.2.4.2.12. LACTOBACILLUS BULGARICUS

9.2.4.2.13. OTHERS

9.2.4.3. STREPTOCOCCUS THERMOPHILUS

9.2.4.4. BACILLUS

9.2.4.5. ENTEROCOCCUS

9.2.4.6. PEDIOCOCCUS

9.2.4.7. PROPIONIBACTERIUM

9.2.4.8. OTHERS

9.3 PREBIOTICS

9.4 DIGESTIVE ENZYMES

9.5 POLYPHENOLS

9.6 OTHERS

10 GLOBAL GUT HEALTH SUPPLEMENTS MARKET , BY CATEGORY, 2020-2029, (USD MILLION)

10.1 OVERVIEW

10.2 ORGANIC

10.3 CONVENTIONAL

11 GLOBAL GUT HEALTH SUPPLEMENTS MARKET , BY FORM, 2020-2029, (USD MILLION)

11.1 OVERVIEW

11.2 TABLETS

11.3 POWDER

11.4 CAPSULES

11.5 GUMMIES

11.6 OTHERS (IF ANY)

12 GLOBAL GUT HEALTH SUPPLEMENTS MARKET , BY END USER, 2020-2029, (USD MILLION)

12.1 OVERVIEW

12.2 ADULTS

12.2.1 MEN

12.2.2 WOMEN

12.3 SENIOR CITIZEN

12.4 PREGNANT WOMEN

12.5 OTHERS

12.5.1 INFANTS

12.5.2 CHILDREN

12.5.3 PETS

13 GLOBAL GUT HEALTH SUPPLEMENTS MARKET , BY DISTRIBUTION CHANNEL, 2020-2029, (USD MILLION)

13.1 OVERVIEW

13.2 STORE BASED

13.2.1 HYPERMARKETS /SUPERMARKETS

13.2.2 CONVENIENCE STORES

13.2.3 PHARMACIES AND DRUG STORES

13.2.4 SPECIALTY STORES

13.2.5 DEPARTMENTAL STORES

13.3 NON STORE BASED

13.3.1 ONLINE RETAIL STORES

13.3.2 VENDING MACHINES

14 GLOBAL GUT HEALTH SUPPLEMENTS MARKET , COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: GLOBAL

14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

14.3 COMPANY SHARE ANALYSIS: EUROPE

14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

14.5 MERGERS & ACQUISITIONS

14.6 NEW PRODUCT DEVELOPMENT & APPROVALS

14.7 EXPANSIONS & PARTNERSHIP

14.8 REGULATORY CHANGES

15 GLOBAL GUT HEALTH SUPPLEMENTS MARKET , BY GEOGRAPHY

OVERVIEW (ALL SEGMENTATION PROVIDED ABOVE IS REPRESNTED IN THIS CHAPTER BY COUNTRY)

15.1 NORTH AMERICA

15.1.1 U.S.

15.1.2 CANADA

15.1.3 MEXICO

15.2 EUROPE

15.2.1 GERMANY

15.2.2 U.K.

15.2.3 ITALY

15.2.4 FRANCE

15.2.5 SPAIN

15.2.6 SWITZERLAND

15.2.7 NETHERLANDS

15.2.8 BELGIUM

15.2.9 RUSSIA

15.2.10 DENMARK

15.2.11 SWEDEN

15.2.12 POLAND

15.2.13 TURKEY

15.2.14 REST OF EUROPE

15.3 ASIA-PACIFIC

15.3.1 JAPAN

15.3.2 CHINA

15.3.3 SOUTH KOREA

15.3.4 INDIA

15.3.5 AUSTRALIA

15.3.6 SINGAPORE

15.3.7 THAILAND

15.3.8 INDONESIA

15.3.9 MALAYSIA

15.3.10 PHILIPPINES

15.3.11 NEW ZEALAND

15.3.12 VIETNAM

15.3.13 REST OF ASIA-PACIFIC

15.4 SOUTH AMERICA

15.4.1 BRAZIL

15.4.2 ARGENTINA

15.4.3 REST OF SOUTH AMERICA

15.5 MIDDLE EAST AND AFRICA

15.5.1 SOUTH AFRICA

15.5.2 UAE

15.5.3 SAUDI ARABIA

15.5.4 OMAN

15.5.5 QATAR

15.5.6 KUWAIT

15.5.7 REST OF MIDDLE EAST AND AFRICA

16 GLOBAL GUT HEALTH SUPPLEMENTS MARKET , SWOT & DBMR ANALYSIS

17 GLOBAL GUT HEALTH SUPPLEMENTS MARKET , COMPANY PROFILE

17.1 CARGILL, INCORPORATED.

17.1.1 COMPANY OVERVIEW

17.1.2 REVENUE ANALYSIS

17.1.3 GEOGRAPHICAL PRESENCE

17.1.4 PRODUCT PORTFOLIO

17.1.5 RECENT DEVELOPMENTS

17.2 ADM

17.2.1 COMPANY OVERVIEW

17.2.2 REVENUE ANALYSIS

17.2.3 GEOGRAPHICAL PRESENCE

17.2.4 PRODUCT PORTFOLIO

17.2.5 RECENT DEVELOPMENTS

17.3 EVONIK INDUSTRIES AG

17.3.1 COMPANY OVERVIEW

17.3.2 REVENUE ANALYSIS

17.3.3 GEOGRAPHICAL PRESENCE

17.3.4 PRODUCT PORTFOLIO

17.3.5 RECENT DEVELOPMENTS

17.4 BIOGAIA

17.4.1 COMPANY OVERVIEW

17.4.2 REVENUE ANALYSIS

17.4.3 GEOGRAPHICAL PRESENCE

17.4.4 PRODUCT PORTFOLIO

17.4.5 RECENT DEVELOPMENTS

17.5 CHR. HANSEN HOLDING A/S

17.5.1 COMPANY OVERVIEW

17.5.2 REVENUE ANALYSIS

17.5.3 GEOGRAPHICAL PRESENCE

17.5.4 PRODUCT PORTFOLIO

17.5.5 RECENT DEVELOPMENTS

17.6 PROBI

17.6.1 COMPANY OVERVIEW

17.6.2 REVENUE ANALYSIS

17.6.3 GEOGRAPHICAL PRESENCE

17.6.4 PRODUCT PORTFOLIO

17.6.5 RECENT DEVELOPMENTS

17.7 YAKULT HONSHA CO.( GROUPE DANONE)

17.7.1 COMPANY OVERVIEW

17.7.2 REVENUE ANALYSIS

17.7.3 GEOGRAPHICAL PRESENCE

17.7.4 PRODUCT PORTFOLIO

17.7.5 RECENT DEVELOPMENTS

17.8 PROVEN PROBIOTICS. (CULTECH)

17.8.1 COMPANY OVERVIEW

17.8.2 REVENUE ANALYSIS

17.8.3 GEOGRAPHICAL PRESENCE

17.8.4 PRODUCT PORTFOLIO

17.8.5 RECENT DEVELOPMENTS

17.9 NATREN UK

17.9.1 COMPANY OVERVIEW

17.9.2 REVENUE ANALYSIS

17.9.3 GEOGRAPHICAL PRESENCE

17.9.4 PRODUCT PORTFOLIO

17.9.5 RECENT DEVELOPMENTS

17.1 UNIQUE BIOTECH

17.10.1 COMPANY OVERVIEW

17.10.2 REVENUE ANALYSIS

17.10.3 GEOGRAPHICAL PRESENCE

17.10.4 PRODUCT PORTFOLIO

17.10.5 RECENT DEVELOPMENTS

17.11 LALLEMAND INC

17.11.1 COMPANY OVERVIEW

17.11.2 REVENUE ANALYSIS

17.11.3 GEOGRAPHICAL PRESENCE

17.11.4 PRODUCT PORTFOLIO

17.11.5 RECENT DEVELOPMENTS

17.12 PFIZER INC.

17.12.1 COMPANY OVERVIEW

17.12.2 REVENUE ANALYSIS

17.12.3 GEOGRAPHICAL PRESENCE

17.12.4 PRODUCT PORTFOLIO

17.12.5 RECENT DEVELOPMENTS

17.13 AMWAY(ALTICOR)

17.13.1 COMPANY OVERVIEW

17.13.2 REVENUE ANALYSIS

17.13.3 GEOGRAPHICAL PRESENCE

17.13.4 PRODUCT PORTFOLIO

17.13.5 RECENT DEVELOPMENTS

17.14 NOVOZYMES A/S

17.14.1 COMPANY OVERVIEW

17.14.2 REVENUE ANALYSIS

17.14.3 GEOGRAPHICAL PRESENCE

17.14.4 PRODUCT PORTFOLIO

17.14.5 RECENT DEVELOPMENTS

17.15 WREN LABORATORIES(OPTIBAC PROBIOTICS)

17.15.1 COMPANY OVERVIEW

17.15.2 REVENUE ANALYSIS

17.15.3 GEOGRAPHICAL PRESENCE

17.15.4 PRODUCT PORTFOLIO

17.15.5 RECENT DEVELOPMENTS

NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST

18 RELATED REPORTS

19 CONCLUSION

20 QUESTIONNAIRE

21 ABOUT DATA BRIDGE MARKET RESEARCH

相關(guān)知識(shí)

纖維補(bǔ)充劑 市場(chǎng)規(guī)模和股份分析
腦健康補(bǔ)充劑市場(chǎng)規(guī)模、份額
膳食補(bǔ)充劑市場(chǎng)規(guī)模、份額和趨勢(shì)
維生素和補(bǔ)充劑市場(chǎng)規(guī)模，份額/行業(yè)預(yù)測(cè)到2030年
膳食補(bǔ)充劑市場(chǎng)規(guī)模，份額，行業(yè)預(yù)測(cè)到2032年
女性健康美容補(bǔ)充劑 市場(chǎng)規(guī)模、份額、范圍、趨勢(shì)和預(yù)測(cè) 2032
2018年中國(guó)膳食補(bǔ)充劑市場(chǎng)分析 國(guó)產(chǎn)品牌市場(chǎng)份額不斷提高
2023年全球騎行服行業(yè)分類、市場(chǎng)規(guī)模及市場(chǎng)份額分析「圖」
醫(yī)療大數(shù)據(jù)解決方案市場(chǎng)競(jìng)爭(zhēng)格局及市場(chǎng)規(guī)模前景分析
低聚半乳糖市場(chǎng)規(guī)模和份額，2036 年增長(zhǎng)報(bào)告

網(wǎng)址: 2029年腸道健康補(bǔ)充劑市場(chǎng)規(guī)模、統(tǒng)計(jì)數(shù)據(jù)和份額分析 http://m.u1s5d6.cn/newsview1477151.html